References
- Buechner SA, Wernli M, Harr T, et al (1997). Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide. J Clin Invest, 100, 2691-6. https://doi.org/10.1172/JCI119814
- Dinney CP, Bielenberg DR, Perrotte P, et al (1998). Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by mice by systemic interferon-a administration. Cancer Res, 58, 808-14.
- Fabra A, Nakajima M, Bucana CD, Fidler IJ (1992). Modulation of the invasive phenotype of human colon carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation, 52, 101-10. https://doi.org/10.1111/j.1432-0436.1992.tb00504.x
- Gohji K, Fidler IJ, Tsan R, et al (1994). Human recombinant interferons-b and g decrease gelatinase production and invasion by human KG-2 renal carcinoma cells. Int J Cancer, 58, 380-4. https://doi.org/10.1002/ijc.2910580313
- Hertzog PJ, Hwang SY, Kola I (1994). Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol Reprod Dev, 39, 226-32. https://doi.org/10.1002/mrd.1080390216
- Ito S, Natsume A, Shimato S, et al (2010). Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma. Cancer Gene Ther, 17, 299-306. https://doi.org/10.1038/cgt.2009.80
- Kageshita T, Mizuno M, Ono T, et al (2001). Growth inhibition of human malignant melanoma transfected with the human interferon-beta gene by means of cationic liposomes. Melanoma Res, 11, 337-42. https://doi.org/10.1097/00008390-200108000-00003
-
Konjevic G, Mirjacic Martinovic K, Vuletic A, Babovic N (2010). In-vitro IL-2 or IFN-
${\alpha}$ -induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients. Melanoma Res, 20, 459-67. https://doi.org/10.1097/CMR.0b013e32833e3286 - Koshiji M, Adachi Y, Sogo S, et al (1998). Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression. Clin Exp Immunol, 111, 211-8. https://doi.org/10.1046/j.1365-2249.1998.00460.x
- Lin W, Zhang X, Wang ZX, et al (2004). Growth inhibition of glioma cell line SHG44 by transfection of human interferon-beta gene liposome. Chin J Neurosurg Dis Res, 3, 226-9.
- Mizuno M, Yoshida J, Sugita K, et al (1990). Growth inhibition of glioma cells transfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res, 50, 7826-9.
- Nakahara N, Pollack IF, Storkus WJ, et al (2003). Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells. Cancer Gene Ther, 10, 549-58. https://doi.org/10.1038/sj.cgt.7700598
- Oliveira IC, Sciavolino PJ, Lee TH (1992). Down regulation of interleukin 8 gene expression in human fibroblasts, unique mechanism of transcriptional inhibition by interferon. Natl Acad Sci USA, 89, 9049-53. https://doi.org/10.1073/pnas.89.19.9049
- Sangfelt O, Erickson S, Castro J, et al (1997). Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines. Cell Growth Differ, 8, 343-52.
- Singh RK, Gutman M, Bucana CD, et al (1995). Interferons alpha and beta down regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad, 92, 4562-6. https://doi.org/10.1073/pnas.92.10.4562
- Wakabayashi T, Kajita Y, Hatano N, et al (2000). Clinicopathological study of oligodendroglial tumors, the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors. Brain Tumor Pathol, 17, 29-33. https://doi.org/10.1007/BF02478915
- Williams RF, Myers AL, Sims TL, Ng CY, Nathwani AC, Davidoff AM (2010). Targeting multiple angiogenic pathways for the treatment of neuroblastoma. J Pediatr Surg, 45, 1103-9. https://doi.org/10.1016/j.jpedsurg.2010.02.073
- Yoshida J, Mizuno M, Wakabayashi T (2004). Interferon-beta gene therapy for cancer, basic research to clinical application. Cancer Sci, 95, 858-65. https://doi.org/10.1111/j.1349-7006.2004.tb02194.x
Cited by
- Induction of Indoleamine 2,3-dioxygenase (IDO) Enzymatic Activity Contributes to Interferon-Gamma Induced Apoptosis and Death Receptor 5 Expression in Human Non-small Cell Lung Cancer Cells vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7995
- Interferon Apha 2b for Treating Patients with JAK2V617F Positive Polycythemia Vera and Essential Thrombocytosis vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1681
- Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells vol.10, pp.10, 2015, https://doi.org/10.1371/journal.pone.0139603
- Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats vol.34, pp.4, 2015, https://doi.org/10.3892/or.2015.4174
- Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies pp.1744-7593, 2017, https://doi.org/10.1080/17425247.2018.1378642